Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914

The effect of age on the non-haemin iron in the human brain

Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

Dexter, D. T., Carter, C. J., Wells, F. R., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

Davis, G. C., Williams, A. C., Markey, S. P., Ebert, M. H., Caine, E. D., Reichert, C. M., & Kopin, I. J. (1979) · Psychiatry Research · doi:10.1016/0165-1781(79)90006-4 · Cited by 1,377

FERRITIN: STRUCTURE, GENE REGULATION, AND CELLULAR FUNCTION IN ANIMALS, PLANTS, AND MICROORGANISMS

Theil, E. C. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.001445 · Cited by 1,337

Increased nigral iron content in postmortem parkinsonian brain

Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963

Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro

Graham, D. G., Tiffany, S. M., BELL, W. R., & Gutknecht, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953

The importance of free radicals and catalytic metal ions in human diseases.

Halliwell, B., & Gutteridge, J. M. C. (1985) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(85)90001-9 · Cited by 941

Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation

Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709

Brain Peroxidase and Catalase in Parkinson Disease

Ambani, L. M., Woert, M. H. V., & Murphy, S. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490440064010 · Cited by 404

Role of Cellular Senescence in Parkinson’s Disease: Potential for Disease-Modification Through Senotherapy

Rademacher, D. J., Exline, J. E., & Foecking, E. M. (2025) · Biomedicines · doi:10.3390/biomedicines13061400 · Cited by 8

Phenotypic characterization of an Atp13a2 knockout rat model of Parkinson’s disease

Kinet, R., Sikora, J., Arotçarena, M.-L., Decourt, M., Balado, É., Doudnikoff, É., Bohic, S., Vesnaver, M., Lovisotto, A., Thiolat, M.-L., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01171-0 · Cited by 6

Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson’s Disease: A Review

Petiet, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.583678 · Cited by 6

Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review

Otani, R. T. V., Yamamoto, J. Y. S., Nunes, D. M., Haddad, M. S., & Parmera, J. B. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2022-s130 · Cited by 6

Synthesis of cyanoaminopyridyl enaminoates for their fluorescent “turn off” response towards Fe( iii ) ions

Devi, L., Sasan, S., Changotra, A., & Kapoor, K. K. (2024) · New Journal of Chemistry · doi:10.1039/d4nj01359j · Cited by 6

Synthesis of novel hydrophilic celastrol nanoformulation by entrapment within calcium phosphate nanoparticle and study of its antioxidant activity against neurotoxin-induced damage in human neuroblastoma cells

Chakrabarty, S., Nandi, S., Bandopadhyay, P., Das, A., Azaharuddin, M., Pal, A., Ghosh, S., Sett, U., Nandy, S., & Basu, T. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150480 · Cited by 6

Hemochromatosis neural archetype reveals iron disruption in motor circuits

Loughnan, R. J., Ahern, J., Boyle, M. E. T., Jernigan, T. L., Hagler, D. J., Iversen, J. R., Frei, O., Smith, D. M. Y., Andreassen, O. A., Zaitlen, N., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp4431 · Cited by 6

Architecture of a functionalized SBA-15 (SBA-Pr-N-BFE) chemosensor for the detection of Fe3+ ions in aqueous media

Ziarani, G. M., Ashtiani, S. T., Mohajer, F., Badiei, A., & Varma, R. S. (2023) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2023.110483 · Cited by 6

Iron storage and transport markers in Parkinson’s disease and MPTP-treated mice

Mash, D. C., Singer, J. T., Pablo, J. P., Basile, M. J., Bruce, J. H., & Weiner, W. J. (1993) · Key topics in brain research · doi:10.1007/978-3-7091-9322-8_9 · Cited by 6

Abnormal Function of Metalloproteins Underlies Most Neurodegenerative Diseases

Kanninen, K. M., & White, A. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00021-x · Cited by 6

Iron and Parkinson’s Disease

Youdim, M. B. H., Ben‐Shachar, D., & Riederer, P. F. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-9203-3_7 · Cited by 6

Parkinsonism induced by MPTP and free radical generation.

Obata, T., & Yamanaka, Y. (2001) · Folia Pharmacologica Japonica · doi:10.1254/fpj.117.105 · Cited by 6

Iron and neurotoxin intoxication: comparative in vitro and in vivo studies

Wesemann, W., Blaschke, S., Clement, H. ‐., Grote, C., Weiner, N., Kolasiewicz, W., & Sontag, K. ‐. (1993) · Key topics in brain research · doi:10.1007/978-3-7091-9322-8_7 · Cited by 6

Oxidative stress in neurobiology: An important role for iron

Gutteridge, J. M. C. (1995) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7337-6_27 · Cited by 6

Dopaminergic Cell Death in Parkinson’s Disease

Javoy-Agid, F. (1992) · Springer eBooks · doi:10.1007/978-3-642-77609-0_8 · Cited by 6

Intranigral Iron Infusion as a Model for Parkinson’s Disease

Arendash, G. W., Sengstock, G. J., Olanow, C. W., Barone, S., & Dunn, A. J. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1447-7_7 · Cited by 6

Epidemiology of Parkinson's Disease: The Rotterdam Study

de Rijk, M. (1997) · RePub (Erasmus University Rotterdam) · Cited by 6

Ferroptosis in neurodegenerative diseases: mechanisms and therapeutic potential of stem cell derivatives

Zhang, T., Zhang, Y., Xie, J., Lu, D., Wang, L., Zhao, S., Zhou, J., Cheng, Y., Kou, T., Wang, J., et al. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1577382 · Cited by 7

EPIGENETIC MECHANISMS IN ALZHEIMER'S DISEASE: STATE-OF-THE-ART

Faltraco, F., Lista, S., Garaci, F., & Hampel, H. (2012) · Cineca Institutional Research Information System (Tor Vergata University) · Cited by 5

Neuroprotective potential of ocimum sanctum (Linn) leaf extract in preventing and attenuating stress induced substantia nigral neuronal damage in rats

Rodrigues, V., Rao, M. S. R., Mohandas Rao, K. G., & Mohandas Rao, K. G. (2022) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2022.100651 · Cited by 5

Detoxification of 6-hydroxydopamine-induced Parkinsonian neurodegeneration by G-CYPMPO, a novel radical trapper

Kitamura, Y., Kamibayashi, M., Inden, M., Yanagida, T., Shibaike, T., Takata, K., Yasui, H., Yamashita, M., & Taniguchi, T. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.02.013 · Cited by 5

The Antioxidative Effect of Carboxyfullerenes (C3/D3) on Iron‐Induced Oxidative Injury in CNS

Lin, A. M.-Y., Luh, T., Chou, C., & Ho, L. T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08012.x · Cited by 5

Multifunctional Enzyme Inhibition for Neuroprotection - A Focus on MAO, NOS, and AChE Inhibitors

Joubert, J., Petzer, J. P., Prins, L. H. A., Repsold, B. P., & Malan, S. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-803959-5.50005-2 · Cited by 5

Reflections on 60 years of publication of the Journal of Neurochemistry

Turner, A. J., Nalivaeva, N. N., Fonnum, F., Tipton, K. F., Hausmann, L., & Schulz, J. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13673 · Cited by 5

Curcumin Derivatives as Metal-Chelating Agents: Implications for Potential Therapeutic Agents for Neurological Disorders

Ferrari, É. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00015-3 · Cited by 5

Inhibition of aggregation and toxicity of α-synuclein in the presence of copper by an N-methylated peptide

Zhou, B., Wang, L., Zhang, J., Liu, Y., & Zhong, M. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128079 · Cited by 4

Nutrient‐sensing amyloid metastasis

Lima, L. M. T. R., & Sisnande, T. (2022) · BioFactors · doi:10.1002/biof.1825 · Cited by 5

Iron chelators of clinical significance

Hider, R. C., & Singh, S. (1993) · Springer eBooks · doi:10.1007/978-94-011-2140-8_8 · Cited by 5

Mitochondrial toxicity of iron and the protective role of ferritin on dopaminergic PC12 cell line

Galvani, P., Colleoni, M., Origgi, M., & Santagostino, A. (1995) · Toxicology in Vitro · doi:10.1016/0887-2333(95)00031-3 · Cited by 5

Current concepts on the etiology and pathogenesis of Parkinson disease

Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00005-6 · Cited by 5

Copper in Brain and Neurodegeneration

Liddell, J. R., Bush, A. I., & White, A. R. (2004) · Encyclopedia of Inorganic and Bioinorganic Chemistry · doi:10.1002/9781119951438.eibc2143 · Cited by 5

Iron In Neurodegeneration

Gałązka-Friedman, J., Bauminger, E. R., & Friedman, A. (2013) · doi:10.1002/9781118714614.ch16 · Cited by 5

Modifiers of Protein Aggregation—From Nonspecific to Specific Interactions

Levy‐Sakin, M., Scherzer‐Attali, R., & Gazit, E. (2012) · Wiley eBooks · doi:10.1002/9781118183373.ch15 · Cited by 5

Oxidative stress in neurodegeneration: in vitro models for investigating cellular damage and neuroprotective strategies

Garip, A., Stefanova, D., & Tzankova, V. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e175265 · Cited by 5

Iron and Selenium: At the Crossroads of Development and Death in Oligodendrocytes

Ma, C., Wurlitzer, K., Nunes, L. G. A., Hoffmann, P. R., & Pitts, M. W. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110509 · Cited by 5

When Pathways Converge: Iron, Lipid Peroxidation, and α‐Synuclein in Ferroptosis‐Driven Dopaminergic Neurodegeneration

Sperlich, C. L., Stockwell, B. R., & Farina, M. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70438 · Cited by 5

Stem Cell Therapy for Parkinson’s Disease: A Review

Gandhi, V., Burle, S. S., & Kosalge, S. B. (2018) · Pharmatutor · doi:10.29161/pt.v6.i6.2018.1 · Cited by 4

Levodopa-induced dyskinesia: brain iron deposition as a new hypothesis

Zhang, F., Ye, Z., Xie, Y., Liu, M., Zhang, L., Zhang, J., & Xu, Z. (2024) · BioMetals · doi:10.1007/s10534-024-00628-8 · Cited by 4

Postencephalitic Parkinsonism: Unique Pathological and Clinical Features—Preliminary Data

Strobel, S., Sian‐Hülsmann, J., Tappe, D., Jellinger, K. A., Riederer, P. F., & Monoranu, C. (2024) · Cells · doi:10.3390/cells13181511 · Cited by 5

Zinc-Dependent Modulation of Dopamine Release and Uptake Is Altered in Parkinson’s Disease Model Zebrafish

Hettiarachchi, P., Shigemoto, A. K., Hickey, E. E., Burdette, S. C., & Johnson, M. A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00864 · Cited by 4

Effect of Water T2 Shortening in the Quantification of in‐vitro Proton MR Spectroscopy

Hernandez-Tamames, J. A., Mato‐Abad, V., García‐Álvarez, R., Gonzalez, J., Loureiro, J. P., & Álvarez‐Linera, J. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12258 · Cited by 4

Clinical trials of promising apoptosis modulating drugs

Sharma, N., Kumari, R. M., Arya, G., Gupta, N., Chandra, R., & Nimesh, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815762-6.00010-x · Cited by 4

Maladie de Parkinson: m�canismes physiopathologiques et effets du pirib�dil

Jenner, P. G. (1993) · Journal of Neurology · doi:10.1007/bf00879099 · Cited by 4

Effects of Intracerebroventricular Injection of Iron Dextran on the Iron Concentration and Divalent Metal Transporter 1 Expression in the Caudate Putamen and Substantia Nigra of Rats

Yu, P., Chang, Y., Miao, W., Wang, S., Cui, R., Qian, Z., Ke, Y., & Duan, X. (2008) · The Anatomical Record · doi:10.1002/ar.20807 · Cited by 4

Use of Mri to Monitor Parkinson’s Disease

Planetta, P. J., Prodoehl, J., Corcos, D. M., & Vaillancourt, D. E. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.10.6 · Cited by 3

Neurotransmitter Receptors

Suppiramaniam, V. D., Bloemer, J., Reed, M. N., & Bhattacharya, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65382-5 · Cited by 4

Brain Iron and other Trace Metals in Neurodegenerative Diseases

Gerlach, M., Youdim, M. B. H., & Riederer, P. F. (2000) · Springer eBooks · doi:10.1007/978-1-4615-1269-1_25 · Cited by 4

Expression of chimeric human transferrin genes in vitro

Fischbach, K., Lu, Y., Tiffany‐Castiglioni, E., Minter, A., Bowman, B. H., & Adrian, G. S. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270424 · Cited by 4

Letter to the editor

Fénelon, G., Percheron, G., Jankovic, J. J., Gerlach, M., Double, K. L., Riederer, P. F., Hirsch, É. C., Jellinger, K. A., Jenner, P. G., TRAUTWEIN, A. X., et al. (1997) · Movement Disorders · doi:10.1002/mds.870120224 · Cited by 4

Zinc in Alzheimer’s and Parkinson’s Diseases

Ayton, S., Finkelstein, D. I., Cherny, R. A., Bush, A. I., & Adlard, P. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-1533-6_214 · Cited by 4

Ferroptosis-related stress during aging and its relevance to disease

Maher, P. A., Soriano‐Castell, D., Dar, N. J., Soriano, S., & Currais, A. J. M. (2025) · GeroScience · doi:10.1007/s11357-025-01929-7 · Cited by 6

Copper, Ceruloplasmin, Zinc, and Manganese Levels in Brain and Biological Fluids from Parkinson’s Disease Patients: Systematic Review and Meta-Analysis

Jiménez-Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., Martín-Gómez, M. Á., Salgado-Cámara, P., Cárcamo-Fonfría, A., Arroyo-Solera, M., & Agúndez, J. A. G. (2026) · Cells · doi:10.3390/cells15030288 · Cited by 4

New Perspectives on oligodendrocytes: Guardians of iron homeostasis and defenders against ferroptosis

Li, F., Tao, S., Wang, S., Ren, T., Qiu, M. S., & Xu, X. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.04.052 · Cited by 3

Lack of Protective Effect by Intermittent Hypoxia on MPTP‐Induced Neurotoxicity in Mice

LAI, G., CHEN, C., Su, Y., Ho, L., & Lin, A. M.-Y. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03609.x · Cited by 3

Magnetic Resonance Spectroscopy in Parkinsonian Disorders

Dydak, U., Edmondson, D. A., & Zauber, S. E. (2016) · Contemporary clinical neuroscience · doi:10.1007/978-3-319-33555-1_5 · Cited by 3

Anti-Oxidants, the Aging Brain and Age-Related Brain Disorders

Baudry, M., & Malfroy-Camine, B. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_13 · Cited by 3

Association of transferrin G258A and transferrin receptor A82G polymorphisms with the risk of Parkinson disease in certain area

Wang, Y., Wang, Y., Zhou, M., Jiang, D.-Q., & Deng, X. (2020) · Medicine · doi:10.1097/md.0000000000023432 · Cited by 3

L-Theanine Effectively Protects Against Copper-Facilitated Dopamine Oxidation: Implication for Relieving Dopamine Overflow-Associated Neurotoxicities

Wang, F., Huang, X., Wang, W., Li, X., Hao, M., Taylor, E. W., & Zhang, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04601-x · Cited by 3

Efficient imaging of midbrain nuclei using inverse double‐echo steady‐state acquisition a)

Wu, M., Chang, H., Chao, T. C., & Chen, N. (2015) · Medical Physics · doi:10.1118/1.4922402 · Cited by 3

Iron Deficiency and Excess in the Brain: Implications for Cognitive Impairment and Neurodegeneration

Youdim, M. B. H., Gerlach, M., & Riederer, P. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-462-9_6 · Cited by 4

Relative assessment of brain iron levels using MRI at 3 tesla

Ordidge, R. J., Gorell, J. M., Deniau, J. C., Knight, R. A., & Helpern, J. A. (1994) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/bf01705295 · Cited by 3

Metal Transporters in Neurodegeneration

Jiang, H. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00016-6 · Cited by 3

Parkinson's Disease: Mechanisms of Neuronal Death

Kolesnikova, E. E., & Serebrovskaya, T. V. (2003) · Neurophysiology · doi:10.1023/a:1023902507735 · Cited by 3

Biology of Oxidative Stress

Ceballos-Picot, I. (1997) · Neuroscience intelligence unit · doi:10.1007/978-3-662-22516-5_2 · Cited by 3

Heme metabolism, mitochondria, and complex I in neuropsychiatric disorders

Ifhar, L. S., & Ben‐Shachar, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814037-6.00008-2 · Cited by 3

Oxidative Stress with Emphasis on the Role of LAMMA in Parkinson’s Disease

Good, P. F., Perl, D. P., & Olanow, C. W. (1997) · Springer eBooks · doi:10.1007/978-1-4899-0197-2_14 · Cited by 3

Chapter 5 Mitochondrial Abnormalities in Neurodegenerative Disorders

Tabrizi, S. J., & Schapira, A. H. V. (2002) · Blue books of practical neurology · doi:10.1016/s1877-3419(09)70064-9 · Cited by 3

Serotonin Binding Proteins: AnIn VitroModel System for Monoamine‐related Neurotoxicitya

Vauquelin, G., Jiménez-Del-Río, M., & Pardo, C. V. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21830.x · Cited by 3

Metallothionein in oxidative stress of Parkinson’s disease

Ebadi, M., Hiramatsu, M., Kumari, M. V. R., Hao, R., & Pfeiffer, R. F. (1999) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8847-9_49 · Cited by 3

Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson’s disease

Mohamed, Y. A., Nadeem, A. A. A., Ismail, L. M., Ghallab, Y. K., Ouédraogo, R. J., Elhelw, J., Ahmed, M., & Tharwat, E. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.12.012 · Cited by 2

Neuromelanin, iron and MRI measurements in midbrain tissues of Parkinson’s and Alzheimer’s subjects

Zucca, F. A., Cassidy, C., Sturini, M., Tuominen, L. J., Adorni, F., Cheung, V., Casella, L., Sulzer, D. L., Pezzoli, G., Isaias, I. U., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1672578 · Cited by 2

Orchestrating pathogenesis: copper ions as the conductor of molecular dysfunction in Parkinson’s disease and therapeutic avenues

Zhang, Z., Cai, Y., & Ls, L. (2026) · Reviews in the Neurosciences · doi:10.1515/revneuro-2025-0134 · Cited by 2

Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson’s disease

Tchung, A., Even, A., & Trudeau, L. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.02.003 · Cited by 3

Metals and Mitochondria in Neurodegeneration

Plascencia‐Villa, G., José–Yacamán, M., & Perry, G. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00015-4 · Cited by 2

Covalent functionalization of polycrystalline silicon nanoribbons applied to Pb(II) electrical detection

Borgne, B. L., Girard, A., Cardinaud, C., Salaün, A., Pichon, L., & Geneste, F. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.04.138 · Cited by 2

The Anti-obesity Agent d-norpseudoephedrine Protects Against Rotenone-induced Parkinson’s Disease in Mice

Abdel‐Salam, O. M. E., El-Shamarka, M. E.-S., & Shaffie, N. (2022) · International Journal of Halal Research · doi:10.18517/ijhr.4.1.1-13.2022 · Cited by 2

ПАТОФИЗИОЛОГИЧЕСКАЯ СВЯЗЬ МЕДИ С НЕЙРОДЕГЕНЕРАТИВНЫМИ РАССТРОЙСТВАМИ (ОБЗОР)

университет», Ф. В. «. Г. Н. И., Pilkevich, N. B., Markovskaya, V. A., университет», Ф. В. «. Г. Н. И., Яворская, О. В., университет», Ф. В. «. Г. Н. И., Смирнова, А. П., & университет», Ф. В. «. Г. Н. И. (2023) · Trace Elements in Medicine (Moscow) · doi:10.19112/2413-6174-2023-24-3-22-30 · Cited by 2

A common variant in the iron regulatory gene ( Hfe ) alters the metabolic and transcriptional landscape in brain regions vulnerable to neurodegeneration

Marshall, S., Neely, E. B., Proctor, E. A., & Connor, J. R. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16171 · Cited by 2

MCM-41 supported imidazole-based dithienylethene: Efficient and recyclable fluorescent chemosensor for Fe3+ ions in aqueous media

Alenazi, M. H., Al‐Betar, A., Alshehri, S., Al-Zahrani, A. A., Al‐Ghamdi, A. A., & Abboud, M. (2025) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2025.114082 · Cited by 2

Magnetic Resonance Imaging of Brain Iron Using A4 Tesla Whole-Body Scanner

Schenck, J. F., Mueller, O. M., Souza, S. P., & Dumoulin, C. L. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3810-3_27 · Cited by 2

Nuclear microscopy in Parkinson's disease

Watt, F., Lee, T., Thong, P. S. P., & Tang, S. M. (1995) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/0168-583x(95)00455-6 · Cited by 2

The effects of repeated administration of a long acting TRH analogue (RX77368), on TSH, T4, T3 and prolactin in patients with motor neuron disease.

Eckland, D. J. A., Modarres-Sadeghi, H., Lightman, S. L., & Guiloff, R. J. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.9.803-a · Cited by 2

Effects of pre- and postnatal zinc exposure on adult rat brain dopamine activity and behavior

Nowak, P. G., Bielaczyc, G., Szkilnik, R., Labus, Ł., Dąbrowska, J., Bortel, A. B., Szczerbak, G., Swoboda, M., Kwieciński, A., & Brus, R. (2006) · Polish Journal of Environmental Studies · Cited by 2

Role of Nutritional Antioxidants in the Prevention and Treatment of Neurodegenerative Disorders

Esposito, E. (2006) · Nutrition and disease prevention · doi:10.1201/9781420019131.ch5 · Cited by 2

Treatment of Neurodegenerative Diseases by Chelators

Ward, R. J., Dexter, D. T., & Crichton, R. R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623892-00153 · Cited by 2

Differences Between Intact and Ovariectomized Hemiparkinsonian Rats in Response to L-DOPA, Melatonin, and L-DOPA/Melatonin Coadministration on Motor Behavior and Cytological Alterations

Gutiérrez-Valdez, A. L., Rodríguez-Lara, V., Anaya-Martı́nez, V., Ordóñez-Librado, J. L., Sanchez-Betancourt, J., Montiel-Flores, E., Erazo, L. R., Tron-Alvarez, R., Aley-Medina, P., Espinosa-Villanueva, J., et al. (2018) · InTech eBooks · doi:10.5772/intechopen.70898 · Cited by 2

Review of environmental chemicals and neurotoxicity : focus on neurological diseases.

Bull, S. (2007) · Europe PMC (PubMed Central) · Cited by 2

Iron and Brain Function

Connor, J. R., & Piñero, D. J. (2005) · Nutrition, brain, and behavior./Nutrition, brain and behavior · doi:10.1201/9780203564554.ch14 · Cited by 2

Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis

Datta, I., Raj, A., & Kaushal, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_10 · Cited by 2

A nomogram based on iron metabolism can help identify apathy in patients with Parkinson’s disease

Jiang-Ting, L., Qu, Y., Gao, H., Jing-Yi, L., Qi-Xiong, Q., Dan-Lei, W., Jing-Wei, Z., Mao, Z., Min, Z., Xiong, Y.-J., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1062964 · Cited by 2

Evidence for genetic causality between iron homeostasis and Parkinson's disease: A two-sample Mendelian randomization study

Chen, H., Xie, W., Chang, Z., Zhang, J., & Xie, D. (2024) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2024.127430 · Cited by 2

Zinc

Beattie, J. H., Malavolta, M., & Korichneva, I. L. (2018) · Healthy ageing and longevity · doi:10.1007/978-3-030-03742-0_4 · Cited by 2

Brain Aging and Trace Elements in Human: Clues into the Pathogenesis of Alzheimer’s Disease

Chazot, G., & Broussolle, E. (1990) · Springer eBooks · doi:10.1007/978-4-431-68120-5_3 · Cited by 1

Treatment of Parkinson's disease with deprenyl (selegiline) and other monoamine oxidase inhibitors

Kieburtz, K. D., & Shoulson, I. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50005-9 · Cited by 2

N-methyl-4-phenylpyridinium (MPP+) potentiates the killing of cultured hepatocytes by catecholamines

Snyder, J. W., Alexander, G. M., Ferraro, T. N., Grothusen, J. R., & Farber, J. L. (1993) · Chemico-Biological Interactions · doi:10.1016/0009-2797(93)90092-d · Cited by 2

Oral Iron Absorption Test: Should It Be Performed Before Starting Treatment with Ferrous Preparations?

Kabat‐Koperska, J., Herdzik, E., Safranow, K., Myślak, M., Domański, L., Różański, J., & Ciechanowski, K. (2003) · Biological Trace Element Research · doi:10.1385/bter:94:1:87 · Cited by 2

Communications

(1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb16587.x · Cited by 2

Neuroprotective Effects of MAO-B Inhibition: Clinical Studies in Parkinson’s Disease

LeWitt, P. A. (1993) · Milestones in drug therapy · doi:10.1007/978-3-0348-6348-3_15 · Cited by 2

Conteúdo de íons paramagnéticos no cérebro e sua correlação com mapas quantitativos de ressonância magnética

Barbosa, J. H. O. (2017) · doi:10.11606/t.59.2017.tde-24042017-213315 · Cited by 2

Untitled work

(2000) · doi:10.1002/1531-8257(200011)15:6

Regional distributions of manganese, iron, copper, and zinc in the brains of 6-hydroxydopamine-induced parkinsonian rats

Tarohda, T., Ishida, Y., Kawai, K., Yamamoto, M., & Amano, R. (2005) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-3423-x · Cited by 95

Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain

Genoud, S., Roberts, B. R., Gunn, A. P., Halliday, G. M., Lewis, S. J. G., Ball, H. J., Hare, D. J., & Double, K. L. (2017) · Metallomics · doi:10.1039/c7mt00244k · Cited by 126

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia

Dexter, D. T., Jenner, P. G., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

Hirsch, E. C., Brandel, J. ‐., Galle, P., Javoy‐Agid, F., & Agid, Y. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08170.x · Cited by 537